Home > Insider Trading > Filing (0001363213-14-000002)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
880771	Sciclone Pharmaceuticals Inc	SCLN	Pharmaceutical Preparations (2834)	943116852

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363213	Friedhelm Blobel	950 Tower Lane, Suite 900 Foster City CA 94404	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-08-31	1,000	$4.24	48,036	No	4	P	Direct
Common Stock	Acquisiton	2013-11-30	1,000	$4.15	49,036	No	4	P	Direct
Common Stock	Acquisiton	2014-02-28	1,000	$3.95	50,036	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2014-03-14	200,000	$0.00	200,000	$4.52
Common Stock	Restricted Stock Unit	Acquisiton	2014-03-14	7,000	$0.00	7,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
200,000		2024-03-14	No	4	A	Direct
266,034			No	4	A	Direct

Footnotes

Purchased under the Issuer's Employee Stock Purchase Plan on August 31, 2013.
Purchased under the issuer's Employee Stock Purchase Plan on November 30, 2013.
Purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2014.
Granted under the Issuer's 2005 Equity Incentive Plan.
25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
Vesting for such RSUs will occur 50% on February 20, 2015 and 50% on February 20, 2016, or on such later date thereafter as the Company's trading window opens if it is not open on either of such dates.